Nebivolol in the treatment of cardiac failure: A double-blind controlled clinical trial
- 1 December 1997
- journal article
- clinical trial
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 3 (4) , 271-276
- https://doi.org/10.1016/s1071-9164(97)90026-9
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A dose-response trial of nebivolol in essential hypertensionJournal of Human Hypertension, 1997
- β-Adrenergic Blockers and Survival in Heart FailureNew England Journal of Medicine, 1996
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Carvedilol for heart failure, with careThe Lancet, 1996
- Medium-term effects of beta-blockade on left ventricular mechanics: A double-blind, placebo-controlled comparison of nebivolol and atenolol in patients with ischemic left ventricular dysfunctionJournal of Cardiac Failure, 1996
- Effects of Carvedilol, a Vasodilator–β-Blocker, in Patients With Congestive Heart Failure Due to Ischemic Heart DiseaseCirculation, 1995
- Use of beta-adrenoceptor blockers in patients with congestive heart failureCardiovascular Drugs and Therapy, 1995
- Nitric oxide mediated venodilator effects of nebivolol.British Journal of Clinical Pharmacology, 1994
- Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathyJournal of the American College of Cardiology, 1993
- NebivololClinical Drug Investigation, 1991